Haleos Labs Limited Share Price

Q: What is the share price of Haleos Labs Limited today?

Haleos Labs Limited share price as on 12 Jun 2026 is ₹0

Pharmaceuticals

NSE: HALEOSLABS Small Cap ISIN: INE320X01016

As on 13 June 2026 at 02:34 IST

Stock Not Traded in NSE

Over 1 Month

-12.30%

Over 6 Months

2.27%

Over 1 Year

15.63%

Over 3 Years

166.12%

Haleos Labs Limited Summary

Close ₹1,403.10

Open ₹1,327

High ₹1,439.90

Low ₹1,325

Volume 250

Net Turnover (in Cr) ₹0.034

52Wk High ₹1,774

52Wk Low ₹1,067

52Wk High / Low

1,067

1,774

Haleos Labs Limited Fundamentals

Key Financial Data

Market Cap (in Cr) ₹424.20

EPS (TTM) 58.80

Book Value (BV) 709.74

Div. Yield 0.11 %

P/E (TTM) 22.97

Price/Book Value 1.90

Delivery % 77.60 %

Face Value 10

Key Ratios

PE Ratio 15.28

PB Ratio 1.66

EV to Sales 1.22

PEG Ratio 0.24

ROA 7.55

ROE 11.45

Debt-Equity 0.46

Net Profit Margin 5.80

Operating Profit Margin 13.10

Haleos Labs Limited Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	349.58	309.79	318.63	351.81	267.37
Total Expenses	323.39	299.94	304.39	331.77	247.81
Profit Before Tax	26.19	9.85	16.59	32.73	19.57
Profit After Tax	18.73	6.33	11.38	25.30	13.56
Operating Profit After Depreciation	34.90	20	21.04	26.21	24.10

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	231.85	223.34	228.36	142.03	129.78
Total Non Current Assets	239.42	235.25	235.77	200.73	176.01
Total Current Assets	150.57	156.08	159.12	156.02	126.29
Total Assets	389.99	391.33	394.89	356.75	302.30
Total Shareholder's Fund	196.56	176.81	168.61	152.23	129.22

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	34.06	24.31	14.70	-11.24	35.17
Net Cash Used In Investing Activities	-15	-18.45	-31.29	-7.14	-26.23
Net Cash Used In Financing Activities	-19.12	-6.56	16.89	10.83	-2.55

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	337.32	303.84	318.12	347.16	261.59
Total Expenses	307.28	284.73	302.10	326.88	242.23
Profit Before Tax	30.04	19.11	18.37	32.98	19.35
Profit After Tax	21.37	13.07	13.22	25.38	13.17
Operating Profit After Depreciation	37.92	28.01	21.12	24.91	23.85

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	150.23	138.23	139.61	98.72	100.83
Total Non Current Assets	180.52	172.88	169.80	149.68	136.32
Total Current Assets	177.79	175.35	167.59	162.32	135.43
Total Assets	358.31	348.24	337.39	312	271.74
Total Shareholder's Fund	197.18	176.23	164.03	151.21	126.34

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	28.03	14.75	4.58	-14.66	21.62
Net Cash Used In Investing Activities	-13.77	-13.75	-27.96	-7.49	-5.94
Net Cash Used In Financing Activities	-14.20	-0.82	22.59	14.63	-7.87

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	75.14	94.78	81.37	82.50	89.11
Total Expenses	70.98	80.73	67.79	70.79	81.69
Profit Before Tax	0.90	8.78	8.49	7.02	3.93
Profit After Tax	0.34	6.65	6.43	4.38	3.48
Operating Profit after Depreciation	6.17	14.23	14	12.71	9.76

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	63.38	80.72	77.84	79.04	85.43
Total Expenses	57.18	69.16	67.05	68.21	79.83
Profit Before Tax	3.17	7.49	7.04	7.48	3.34
Profit After Tax	2.23	5.41	4.98	5.16	2.68
Operating Profit after Depreciation	7.17	11.64	11.23	11.84	7.80

Haleos Labs Limited Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,338.77

S2 1,274.43

S3 1,223.87

Pivot 1,389.33

R1 1,453.67

R2 1,504.23

R3 1,568.57

Moving Average

20 SMA 1,519.47

50 SMA 1,443.23

100 SMA 1,350.73

200 SMA 1,289.85

Haleos Labs Limited Corporate Actions

Haleos Labs Limited

₹1.5/Share

Announcement Date 24 Sep 2025

Record Date 24 Sep 2025

Div Yield 15%

AGM Date: 30 Sep 2021

AGM 30/09/2021 SMS Lifesciences India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Outcome of 15th Annual General Meeting held on September 30, 2021. (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

Enclosed is the Outcome of the Board Meeting. Events calendar related to the 16th Annual General Meeting (As Per BSE Announcement Dated on 30/08/2022) Enclosed is the notice of 16th Annual General Meeting of the Company. (As Per BSE Announcement Dated 08.09.2022) Outcome of 16th Annual General Meeting held on September 30, 2022 along with Scrutinizer Report. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 29 Sep 2023

Enclosed is the Outcome of the Board Meeting (Q1F24 Results / AGM date / Board Report approval). Register of members and Share Transfer Books of the Company will remain closed from Saturday, September 23, 2023 to Friday, September 29, 2023 (both days inclusive) & record date for Dividend and AGM will be Friday, September 22, 2023. (As per BSE Announcement Dated on 22/08/2023) Enclosed is the notice of the 17th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 07/09/2023) Outcome of the 17th Annual General Meeting held on September 29, 2023, along with Scrutinizers Report. (As Per BSE Announcement dated on 29.09.2023)

AGM Date: 30 Sep 2024

Outcome of Board meeting Register of members and share transfer books of the Company will remain closed from Tuesday, September 24, 2024 to Monday, September 30, 2024 and the Record date for dividend and AGM will be Monday, September 23, 2024. (As Per BSE Announcement dated on 24.08.2024) Outcome of 18th Annual General Meeting of the Company. (As per BSE Announcement dated on 30/09/2024)

AGM Date: 30 Sep 2025

Events Calendar related to the 19th Annual General Meeting. Summary of proceedings of 19th Annual General Meeting. (As Per BSE Announcement Dated on: 30.09.2025) Voting result of 19th Annual General Meeting. (As Per BSE Announcement Dated on:01.10.2025)

Haleos Labs Limited Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Haleos Labs Limited Top Mutal Funds Invested

No data available

Haleos Labs Limited News

Board of Haleos labs recommends final dividend

Of Rs 1.5 per share

30 May 2026, 05:40 pm

Haleos labs schedules board meeting

On 29 May 2026

23 May 2026, 05:56 pm

Haleos labs to convene board meeting

On 11 February 2026

05 Feb 2026, 03:36 pm

SMS LifeSciences India announces board meeting date

On 10 November 2025

05 Nov 2025, 04:14 pm

SMS LifeSciences India AGM scheduled

On 30 September 2025

29 Aug 2025, 03:54 pm

Haleos Labs Limited Stock Analysis

Annual revenue for Haleos Labs Limited increased by 11.02% to ₹337.32 crore in FY 2025 from ₹303.84 crore in FY 2024.
Annual Net Profit for Haleos Labs Limited increased by 63.57% to ₹21.37 crore in FY 2025 from ₹13.07 crore in FY 2024.
Promoter Shareholding in Haleos Labs Limited increased by 0.43% in the most recent quarter, from 71.80% in December 2025 to 72.11% in March 2026.
Haleos Labs Limited delivered a 1-year return of 15.63% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Haleos Labs Limited share price moved down by 100.00% from its previous close of INR ₹1,403.10. The latest Haleos Labs Limited share price is INR ₹0.
Haleos Labs Limited share price today has been at a low of 1,399.60 and a high of 1,417.20. Over the past 52 weeks, the Haleos Labs Limited share price has seen a low of 1,067 and a high of 1,774.